Pharmaceutical Business Confidence Report Q1 2014


Posted February 21, 2014 by sarahjohnsonn

Overall, 74% and 60% of global pharmaceutical industry executives are optimistic about the future growth prospects of both their company and the industry, respectively, over the next 6 months.

 
Product Synopsis
Pharmaceutical Business Confidence Report Q1 2014 is a new report by Kable that analyzes pharmaceutical industry executives views on the global economy, expectations on customer confidence, supplier prices, key business concerns, and how executives future investments are set to change in Q1 2014. This report also gives you access to regional analysis of industry outlook, industry and company growth prospects, future opportunities, staff hiring, and sales performance.

Introduction and Landscape
Why was the report written?
This report is the result of an extensive survey drawn from Kables exclusive panel of leading global pharmaceutical industry executives. The report analyzes current economic conditions prevailing across the globe and their impact on the pharmaceutical industry, and forecasts company and industry growth prospects over the next six months. Furthermore, it provides information about the impact of customer confidence, supplier prices, and staff headcount likely to affect the investment decisions of the industry over the next six months. Additionally, this report tracks the change in executives perceptions during the last three months, by providing a comparative analysis of survey results with the previous quarter.

What makes this report unique and essential to read?
Pharmaceutical Business Confidence Report Q1 2014 is a new report by Kable that analyzes the industry sentiments globally on the latest economic and customer issues and their impact upon investment decisions and growth prospects within the pharmaceutical industry. This report also examines the executive opinion about the current and future state of the economy and its retrospective effect on the industry. Furthermore, it analyzes the likely effect of supplier price changes, sales performance, and staff headcount within the industry over the next six months. In addition, it provides an overview of the key priorities, threats, and opportunities for the global pharmaceutical industry over the next six months. Furthermore, it also tracks the change in industry executives thought process, by providing a comparative analysis of survey results with Q4 2013, wherever applicable.

Key Features and Benefits
Project industry trends and industry growth expectations in the next six months, and understand business confidence to make informed business decisions.
The report drives revenues by understanding future product investment areas and key growth regions.
Readers will be provided with a clear uncovering of key challenges and opportunities, and identify the key priorities likely to affect growth prospects of the industry.
The report clearly forecasts the change in supplier prices for various products, which are likely to influence the industrys growth prospects over the next six months.
Identifies the major changes in customer confidence levels in the pharmaceutical industry over the next six months.
To order this report:
Email: [email protected]
US: +1-800-986-6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE: Researchonglobalmarkets.com


RELATED LINK:
http://www.researchonglobalmarkets.com/pharmaceutical-business-confidence-report-q1-2014.html
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Researchonglobalmarket
Website Pharmaceutical Business Confidence Report | Market Research
Phone 91 22 4098 7600
Business Address Mumbai
Country India
Categories Business
Tags market research report , pharmaceutical business confidence report
Last Updated February 21, 2014